Rex Bright - Jul 19, 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Director
Signature
/s/ Mutya Harsch, attorney-in-fact for Rex Bright
Stock symbol
VYNE
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
4
Date filed
7/20/2021, 05:05 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYNE Stock Options Award $0 +20.5K $0.00 20.5K Jul 19, 2021 Common Stock 20.5K $2.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022.